271 related articles for article (PubMed ID: 25195113)
1. [Stereotactic body radiation therapy in the management of liver tumours].
Jacob J; Nguyen F; Deutsch E; Mornex F
Cancer Radiother; 2014 Oct; 18(5-6):486-94. PubMed ID: 25195113
[TBL] [Abstract][Full Text] [Related]
2. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours.
Petersen JB; Lassen Y; Hansen AT; Muren LP; Grau C; Høyer M
Acta Oncol; 2011 Aug; 50(6):823-8. PubMed ID: 21767180
[TBL] [Abstract][Full Text] [Related]
3. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
[TBL] [Abstract][Full Text] [Related]
4. [Hepatic tumors and radiotherapy].
Rio E; Mornex F; Peiffert D; Huertas A
Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
[TBL] [Abstract][Full Text] [Related]
5. [Tolerance of hypofractionated stereotactic radiotherapy for hepatic tumours].
Le Bon M; Lapeyre M; Moreau J; Bellière-Calandry A; Pezet D; Abergel A; Bellini R; Kwiatkowski F; Verrelle P; Martin F; Benoît C
Cancer Radiother; 2019 Sep; 23(5):385-394. PubMed ID: 31300328
[TBL] [Abstract][Full Text] [Related]
6. Robotic stereotactic body radiation therapy for tumors of the liver: radiation-induced liver disease, incidence and predictive factors.
Janoray G; Chapet S; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
Cancer Radiother; 2014 Jun; 18(3):191-7. PubMed ID: 24837351
[TBL] [Abstract][Full Text] [Related]
7. Conformal and stereotactic radiotherapy in hepatocellular carcinoma.
Scorsetti M; Bignardi M
Ann Ital Chir; 2008; 79(2):107-10. PubMed ID: 18727272
[TBL] [Abstract][Full Text] [Related]
8. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
9. Hepatic tumours and radiotherapy.
Rio E; Mornex F; Maingon P; Peiffert D; Parent L
Cancer Radiother; 2022; 26(1-2):266-271. PubMed ID: 34953707
[TBL] [Abstract][Full Text] [Related]
10. [Stereotactic body radiation therapy for hepatic malignancies: Organs at risk, uncertainties margins, doses].
Lacornerie T; Rio E; Mahé MA
Cancer Radiother; 2017 Oct; 21(6-7):574-579. PubMed ID: 28844506
[TBL] [Abstract][Full Text] [Related]
11. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
[TBL] [Abstract][Full Text] [Related]
12. [Follow-up after stereotactic body radiation therapy for liver tumours: A review of the literature and recommendations].
Janoray G; Mornex F
Cancer Radiother; 2015 Oct; 19(6-7):573-81. PubMed ID: 26341312
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy for liver tumors.
Maingon P; Nouhaud É; Mornex F; Créhange G
Cancer Radiother; 2014; 18(4):313-9. PubMed ID: 24958684
[TBL] [Abstract][Full Text] [Related]
14. Gating and tracking, 4D in thoracic tumours.
Verellen D; Depuydt T; Gevaert T; Linthout N; Tournel K; Duchateau M; Reynders T; Storme G; De Ridder M
Cancer Radiother; 2010 Oct; 14(6-7):446-54. PubMed ID: 20673737
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma.
Bujold A; Dawson LA
Cancer Radiother; 2011 Feb; 15(1):54-63. PubMed ID: 21239204
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.
Klein J; Korol R; Lo SS; Chu W; Lock M; Dorth JA; Ellis RJ; Mayr NA; Huang Z; Chung HT
Future Oncol; 2014 Nov; 10(14):2227-41. PubMed ID: 25471036
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy for intrathoracic metastases].
Giraud P; Lacornerie T; Mornex F
Cancer Radiother; 2016 Sep; 20 Suppl():S157-60. PubMed ID: 27523413
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
[TBL] [Abstract][Full Text] [Related]
19. [Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver].
Debbi K; Janoray G; Scher N; Deutsch É; Mornex F
Cancer Radiother; 2017 Oct; 21(6-7):604-612. PubMed ID: 28893525
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the therapeutic response after stereotactic body radiation therapy for liver tumors].
Janoray G; Barillot I; Calais G
Cancer Radiother; 2014; 18(4):320-4. PubMed ID: 24811896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
